Page:United States Statutes at Large Volume 121.djvu/921

From Wikisource
Jump to navigation Jump to search
This page needs to be proofread.
[121 STAT. 900]
PUBLIC LAW 110-000—MMMM. DD, 2007
[121 STAT. 900]

121 STAT. 900

PUBLIC LAW 110–85—SEPT. 27, 2007

year 2008 and such sums as may be necessary for each of fiscal years 2009 through 2012.’’.

TITLE VII—CONFLICTS OF INTEREST SEC. 701. CONFLICTS OF INTEREST.

(a) IN GENERAL.—Subchapter A of chapter VII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 371 et seq.) is amended by inserting at the end the following: 21 USC 379d–1.

‘‘SEC. 712. CONFLICTS OF INTEREST.

dkrause on GSDDPC44 with PUBLAW

‘‘(a) DEFINITIONS.—For purposes of this section: ‘‘(1) ADVISORY COMMITTEE.—The term ‘advisory committee’ means an advisory committee under the Federal Advisory Committee Act that provides advice or recommendations to the Secretary regarding activities of the Food and Drug Administration. ‘‘(2) FINANCIAL INTEREST.—The term ‘financial interest’ means a financial interest under section 208(a) of title 18, United States Code. ‘‘(b) APPOINTMENTS TO ADVISORY COMMITTEES.— ‘‘(1) RECRUITMENT.— ‘‘(A) IN GENERAL.—The Secretary shall— ‘‘(i) develop and implement strategies on effective outreach to potential members of advisory committees at universities, colleges, other academic research centers, professional and medical societies, and patient and consumer groups; ‘‘(ii) seek input from professional medical and scientific societies to determine the most effective informational and recruitment activities; and ‘‘(iii) take into account the advisory committees with the greatest number of vacancies. ‘‘(B) RECRUITMENT ACTIVITIES.—The recruitment activities under subparagraph (A) may include— ‘‘(i) advertising the process for becoming an advisory committee member at medical and scientific society conferences; ‘‘(ii) making widely available, including by using existing electronic communications channels, the contact information for the Food and Drug Administration point of contact regarding advisory committee nominations; and ‘‘(iii) developing a method through which an entity receiving funding from the National Institutes of Health, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, or the Veterans Health Administration can identify a person who the Food and Drug Administration can contact regarding the nomination of individuals to serve on advisory committees. ‘‘(2) EVALUATION AND CRITERIA.—When considering a term appointment to an advisory committee, the Secretary shall review the expertise of the individual and the financial disclosure report filed by the individual pursuant to the Ethics in Government Act of 1978 for each individual under consideration

VerDate Aug 31 2005

13:52 Jan 23, 2009

Jkt 059194

PO 00001

Frm 00898

Fmt 6580

Sfmt 6581

M:\STATUTES\2007\59194PT1.001

APPS10

PsN: 59194PT1